Press release
Imatinib Drug Market Report- Business Review, Technology, Top Companies and Trends | Glenmark Pharmaceuticals Ltd.
The Imatinib Drug Market research report studies the competitive development of the Imatinib Drug Market, such as agreements, new product launches, expansions, and acquisitions in the market. In addition, Imatinib Drug Market provides a region-wise study of the market, including North America, Asia Pacific, Latin America, Middle East, Africa, and Europe. It helps stakeholders understand market players and analyze the top 25 organizations based on their product footprint, market strength, and position. Moreover, Imatinib Drug Market also focuses on market performance during the estimated period.Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5442379
Imatinib Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Imatinib Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- Tablets
- Capsules
Segment by Application
- Chronic Myelogenous Leukemia
- Gastrointestinal Stromal Tumors
- Others
By Company
- Novartis
- Glenmark Pharmaceuticals Ltd.
- Sun Pharmaceuticals
- Actavis Generics
- Dr. Reddy's Laboratories
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Cipla Inc.
- Apotex Inc.
- Mylan Pharms Inc.
Get Discount on Purchase this Report @ https://www.reportsnreports.com/purchase.aspx?name=5442379
Table of Contents-
1 Study Coverage
1.1 Imatinib Drug Product Introduction
1.2 Market by Type
1.2.1 Global Imatinib Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsules
1.3 Market by Application
1.3.1 Global Imatinib Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Chronic Myelogenous Leukemia
1.3.3 Gastrointestinal Stromal Tumors
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Imatinib Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Imatinib Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Imatinib Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Imatinib Drug Sales by Region
2.4.1 Global Imatinib Drug Sales by Region (2017-2022)
2.4.2 Global Sales Imatinib Drug by Region (2023-2028)
2.5 Global Imatinib Drug Revenue by Region
2.5.1 Global Imatinib Drug Revenue by Region (2017-2022)
2.5.2 Global Imatinib Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Imatinib Drug Sales by Manufacturers
3.1.1 Global Top Imatinib Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Imatinib Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Imatinib Drug in 2021
3.2 Global Imatinib Drug Revenue by Manufacturers
3.2.1 Global Imatinib Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Imatinib Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Imatinib Drug Revenue in 2021
3.3 Global Imatinib Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Imatinib Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Imatinib Drug Sales by Type
4.1.1 Global Imatinib Drug Historical Sales by Type (2017-2022)
4.1.2 Global Imatinib Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Imatinib Drug Sales Market Share by Type (2017-2028)
4.2 Global Imatinib Drug Revenue by Type
4.2.1 Global Imatinib Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Imatinib Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Imatinib Drug Revenue Market Share by Type (2017-2028)
4.3 Global Imatinib Drug Price by Type
4.3.1 Global Imatinib Drug Price by Type (2017-2022)
4.3.2 Global Imatinib Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Imatinib Drug Sales by Application
5.1.1 Global Imatinib Drug Historical Sales by Application (2017-2022)
5.1.2 Global Imatinib Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Imatinib Drug Sales Market Share by Application (2017-2028)
5.2 Global Imatinib Drug Revenue by Application
5.2.1 Global Imatinib Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Imatinib Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Imatinib Drug Revenue Market Share by Application (2017-2028)
5.3 Global Imatinib Drug Price by Application
5.3.1 Global Imatinib Drug Price by Application (2017-2022)
5.3.2 Global Imatinib Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Imatinib Drug Market Size by Type
6.1.1 North America Imatinib Drug Sales by Type (2017-2028)
6.1.2 North America Imatinib Drug Revenue by Type (2017-2028)
6.2 North America Imatinib Drug Market Size by Application
6.2.1 North America Imatinib Drug Sales by Application (2017-2028)
6.2.2 North America Imatinib Drug Revenue by Application (2017-2028)
6.3 North America Imatinib Drug Market Size by Country
6.3.1 North America Imatinib Drug Sales by Country (2017-2028)
6.3.2 North America Imatinib Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Imatinib Drug Market Size by Type
and more..
+ 1 888 391 5441
sales@reportsandreports.com
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Imatinib Drug Market Report- Business Review, Technology, Top Companies and Trends | Glenmark Pharmaceuticals Ltd. here
News-ID: 2562285 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Imatinib
Imatinib Mesylate Drugs Market By Industry Research, Supply, Size, Share and Pro …
The "Imatinib Mesylate Pharmaceuticals Market" 2023 research report offers insight into a global business study with key competitors functioning in the sector and a look at how the market will likely compete in the future. The Imatinib Mesylate Drugs market report created by our experts is a fantastic piece of work that takes into account obstacles and chances while also considering the growth of Imatinib Mesylate Drugs, shares, and revenue…
Global Imatinib Drug Market Size | COVID-19 Impact Analysis | Forecast to 2027
The global imatinib drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to accelerate the growth of the market includes an increase in the prevalence of cancer and an increase in demand for target drug therapy. For instance, according to National Cancer Institute in 2017, the number of new leukemia cases was 62,130 and the number of mortalities…
Imatinib Drug Market Report: Industry Trends, Size, Revenue, Applications, Typ …
The Imatinib Drug Market is expected to register a CAGR of 3% during the forecast period.
The Global Imatinib Drug Market is predicted to grow significantly over the forecast period. The global incidence of leukaemia, as well as an increase in healthcare professionals' approval of the imatinib drug, are propelling Global Imatinib Drug Market growth. Gastrointestinal Stromal Tumor has seen a significant growth in imatinib demand, and it is projected…
Imatinib Drug Market Growth, Size, Share, Industry Report and Forecast 2020-2026
FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the…
Imatinib Drug Market Size, Share, Growth, Industry Analysis, Opportunities and F …
FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the…
Imatinib Drug Market Size, Competitive Analysis, Share, Forecast- 2020-2026
The global imatinib drug market is estimated to grow at a CAGR of around 4% during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of cancer and an increase in awareness programs towards cancer by government and private organizations. Imatinib is a chemotherapy drug that used to slow down or stopping the growth of the cancer cells. This medication is used…
